Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China flag China · Delayed Price · Currency is CNY
26.45
-0.73 (-2.69%)
At close: Jun 2, 2026

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Pharmaceutical Business
427.18M426.01M483.10M548.95M511.66M
Pharmaceutical Business Growth
0.27%-11.82%-12.00%7.29%9.60%
Unallocated Other Business
5.55M3.46M6.19M19.26M10.03M
Unallocated Other Business Growth
60.47%-44.10%-67.86%92.00%0.47%
Total
432.73M429.47M489.29M568.21M521.70M
Total Growth
0.76%-12.23%-13.89%8.92%9.40%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Abroad
198.43M211.23M307.89M370.64M355.71M
Abroad Growth
-6.06%-31.39%-16.93%4.20%-0.77%
China
234.30M218.24M181.40M197.57M165.98M
China Growth
7.36%20.31%-8.19%19.03%40.20%
Total
432.73M429.47M489.29M568.21M521.70M
Total Growth
0.76%-12.23%-13.89%8.92%9.40%
Source: S&P Global Market Intelligence.